14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 FGEN stock ended at $1.14. This is 0.88% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 9.43% from a day low at $1.12 to a day high of $1.22.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical FibroGen prices

Date Open High Low Close Volume
Aug 26, 2021 $11.77 $11.87 $11.32 $11.45 2 302 662
Aug 25, 2021 $12.05 $12.10 $11.59 $11.87 1 431 095
Aug 24, 2021 $12.26 $12.26 $11.82 $12.10 976 689
Aug 23, 2021 $12.24 $12.60 $12.01 $12.21 2 181 479
Aug 20, 2021 $12.02 $12.20 $11.70 $12.11 2 051 072
Aug 19, 2021 $11.99 $12.17 $11.47 $11.47 1 268 194
Aug 18, 2021 $12.05 $12.75 $11.98 $12.06 1 953 643
Aug 17, 2021 $11.82 $12.16 $11.75 $11.97 1 361 165
Aug 16, 2021 $12.23 $12.47 $12.02 $12.02 988 718
Aug 13, 2021 $12.62 $12.72 $12.35 $12.40 716 119
Aug 12, 2021 $12.35 $12.65 $12.12 $12.59 1 042 186
Aug 11, 2021 $13.00 $13.44 $12.16 $12.43 2 806 992
Aug 10, 2021 $13.31 $13.40 $12.78 $13.19 1 861 254
Aug 09, 2021 $13.80 $14.11 $13.67 $13.79 712 618
Aug 06, 2021 $13.72 $13.81 $13.43 $13.73 1 008 546
Aug 05, 2021 $13.36 $13.93 $13.31 $13.84 981 795
Aug 04, 2021 $13.30 $13.68 $13.16 $13.40 699 551
Aug 03, 2021 $13.35 $13.39 $13.03 $13.28 603 787
Aug 02, 2021 $13.14 $13.60 $12.98 $13.32 909 361
Jul 30, 2021 $12.90 $13.25 $12.86 $13.00 739 544
Jul 29, 2021 $13.26 $13.49 $12.77 $12.84 1 020 662
Jul 28, 2021 $13.20 $13.48 $13.12 $13.31 1 159 071
Jul 27, 2021 $13.04 $13.25 $12.54 $13.05 1 105 973
Jul 26, 2021 $13.25 $13.62 $12.94 $13.08 917 624
Jul 23, 2021 $13.65 $13.73 $13.11 $13.27 1 724 635
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT